Absci (ABSI) Tax Rate (2021 - 2026)

Absci (ABSI) posted Tax Rate of 0.06% for Q1 2026, down 111.16% sequentially from 0.55% in Q4 2025, and down 8.0% YoY from 0.07% in Q1 2025.

Analysis

Absci (ABSI) Tax Rate (2021 - 2026) Analysis & Trends

Absci has reported Tax Rate for 6 years, with the latest figure at 0.06% in Q1 2026.

Quarterly Tax Rate fell 8.0% year-over-year to 0.06% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.08% (down 3.0% YoY) and the FY2025 annual result came in at 0.06%, up 1.0% from the prior year.
Tax Rate eased to 0.06% in Q1 2026 per ABSI's latest filing, from 0.55% in the prior quarter.
Over five years, Tax Rate peaked at 2.5% in Q4 2022 and troughed at 2.15% in Q1 2022.
A 5-year average of 0.09% and a median of 0.06% in 2024 frame the typical range for Tax Rate.
The sharpest annual moves came in 2022 and 2023: Tax Rate slumped 1103 bps in 2022, then soared 212 bps in 2023.
Over 5 years, Tax Rate stood at 2.5% in 2022, then slumped by 108 bps to 0.2% in 2023, then jumped by 65 bps to 0.07% in 2024, then surged by 852 bps to 0.55% in 2025, then slumped by 111 bps to 0.06% in 2026.
According to Business Quant data, Tax Rate over the past three periods registered 0.06%, 0.55%, and 0.36% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	140.22 Bn	132.37 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	86.04 Bn	78.05 Bn	3.93 Bn	15.11%
3	Argenx Se	63.70 Bn	58.52 Bn	1.37 Bn	-10.89%
4	Moderna	57.56 Bn	52.42 Bn	52.00 Mn	-1.96%
5	Revolution Medicines	44.05 Bn	44.05 Bn	-	-
6	BeOne Medicines	40.16 Bn	35.06 Bn	1.53 Bn	24.15%
7	Alnylam Pharmaceuticals	35.63 Bn	32.32 Bn	992.69 Mn	7.49%
8	Royalty Pharma	28.63 Bn	27.79 Bn	-	-
9	Insmed	27.73 Bn	26.57 Bn	358.27 Mn	-16.71%
10	Absci	1.41 Bn	1.21 Bn	-	-0.12%

Historic Data

Download Data